According to Mediclinic International's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.23116. At the end of 2022 the company had a P/S ratio of 0.6184.
Year | P/S ratio | Change |
---|---|---|
2022 | 0.6184 | 12.2% |
2021 | 0.5511 | -9.16% |
2020 | 0.6067 | 3.01% |
2019 | 0.5890 | -38.57% |
2018 | 0.9588 | -28.86% |
2017 | 1.35 | -45.16% |
2016 | 2.46 |